Frontiers in Psychiatry, 9, 44
The consumer survey data Pendulum cites a consumer study of 274 people taking GLP-1 Probiotic for six weeks, with 91 percent reporting reduced food cravings
In another study conducted in mice with Alzheimer disease in the final stage, intraperitoneal liraglutide improved spatial memory, reduced amyloid deposition and inflammation, and increased dentate gyrus neurogenesis, suggesting that, besides exerting preventive effects, this GLP-1RA may reverse some of the key pathological findings of Alzheimer disease
The simultaneous activation of these three receptors leads to a comprehensive suite of metabolic benefits
they should not be taken as guaranteed outcomes: Weeks 14: Participants typically begin at a low starting dose to minimise gastrointestinal side effects
They may recommend taking a lower dose for longer until you feel better . Dr Crystal Wyllie, Online Doctor